rituximabantimalarialsSLElupusThrombocytopeniaMohammed VI University Hospital
…d with other systemic manifestations, except in two cases where rituximab was required for refractory thrombocytopenia.Conclusions Thromb…
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 181–240 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
Clarithromycin17Antibiotic17Anticoagulants17fludarabine17Inclisiran16Atropine16Secukinumab16Caffeine16Salbutamol16Ondansetron16Dapagliflozin16Naloxone16Methylene blue16Anakinra16Fluconazole16Rilpivirine16Analgesics16Rocuronium16Proton pump inhibitor16Osimertinib15Atogepant15ELAFIBRANOR15Pirfenidone15Dabigatran15Obinutuzumab15Rosuvastatin15Medicines15Amphotericin B15Ketorolac15Carbon Monoxide15ACE inhibitors15Phenylephrine15Glucocorticoid15non-steroidal anti-inflammatory drugs15Empagliflozin14Rimegepant14Fremanezumab14FeNO14Olaparib14GA14Relatlimab14IL-1214Lactulose14SpironolacTone14Mannitol14Levothyroxine14bleomycin14Sodium-glucose cotransporter 2 inhibitors14Beta Blockers14Axicabtagene Ciloleucel14adrenaline14Broad-spectrum antibiotics14Etoposide14Tenofovir14Intravenous Immunoglobulin14UPA13LMWH13Liposomal bupivacaine13Baricitinib13Ruxolitinib13
Articles mentioning drugs
10,506 articles · page 532 of 876prednisoloneSLEpreeclampsiaAPSperipartum cardiomyopathy
…n section at 31 weeks. During 15 days prior to delivery she had prednisolone in her daily therapy for joint pain, which started recently.Aft…
96.0%
prednisoneSLESLE-DAScorticosteroid (CS) therapyCS therapy
….05). Among patients receiving CS, median FACIT-F scores across prednisone dose groups (<=5 mg, >5–<=10 mg, >10 mg) were 18, 30, and 30, r…
prednisoneSystemic lupus erythematosusSLE
…d no activity on a major organ, physician global assessment<=1, prednisone daily dose<=7.5mg/d, immunosuppressive drugs on maintenance dos…
hydroxychloroquineglucocorticoidsSLEsystemic lupus erythematosusDanish ethics committee
…ria; 35% were persistently aPL positive. All patients initiated hydroxychloroquine ± glucocorticoids ± other immunosuppressants according to stand…
belimumabrituximabSLEmucocutaneous disease
…ntibodies are associated with response to rituximab followed by belimumab. This study aimed to investigate IgA2+ B cells in SLE using 5’ …
prednisolonehydroxychloroquinesystemic lupus erythematosusSLE
…AS) and treated with antimalarials only, and were not receiving prednisolone. We assessed differential gene expression, interferon (IFN) sig…
glucocorticoidsantimalarialsSystemic lupus erythematosusToronto Lupus ClinicSLE-mortalitySLE
…sits to the clinic over longer follow-ups, with higher doses of glucocorticoids and antimalarials, higher disease activity, irreversible damage…
cyclophosphamideSLEinvasive squamous cell carcinomauniversity hospitalHSILanal intraepithelial neoplasiaHigh-Grade Squamous Intraepithelial Lesions
…PV-positive; 55.5% with high-risk serotypes; 22.2% had received cyclophosphamide).One middle-aged woman developed stage IIIB squamous cell carci…
antimalarialstopical corticosteroidsCutaneous lupus erythematosusBiogenimmunosuppressantssystemic lupus erythematosusCLEErythemaCLA-IGA-R
… anxiety (13.9%). Participants’ current CLE treatments included antimalarials (69.7%), topical corticosteroids (50.8%), and immunosuppressant…
SLEDAISF-36SLEsystemic lupus erythematosusShort Form 36 Health SurveyJaccoud’s arthropathy
…s/minus 1.8) and correlated with HAQ-DI (r=0.72). Patients with SLEDAI greater than 6 reported greater exertion (16.2 plus/minus 1.9 v…
steroidSystemic Lupus ErythematosusSystemic SclerosisdermatomyositisSLEtertiary paediatric centreuCTDDMJSLEJDM+1 more
…(n=6) were on biologics. 45% (n=11) were on steroid, making the steroid burden very high. The patients’ PWV was 6.7, compared to 6.5 in…